S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.06%) $0.927
USD/NOK
(0.28%) $10.87
USD/GBP
(0.07%) $0.793
USD/RUB
(-0.16%) $92.43

Realtime updates for Werewolf Therapeutics, [HOWL]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
100.00%
return 4.77%
SELL
50.00%
return 0.81%
Last Updated28 Mar 2024 @ 16:00

2.05% $ 6.48

BUY 70275 min ago

@ $6.85

Issued: 9 Feb 2024 @ 10:56


Return: -5.40%


Previous signal: Feb 8 - 11:03


Previous signal: Sell


Return: 3.95 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer...

Stats
Today's Volume 152 663
Average Volume 258 267
Market Cap 276.94M
EPS $0 ( 2024-03-28 )
Next earnings date ( $-0.350 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -6.17
ATR14 $0.0210 (0.33%)
Insider Trading
Date Person Action Amount type
2024-01-04 Atkins Michael B. Buy 35 000 Stock Option (right to buy)
2024-01-04 Atkins Michael B. Sell 0 Common Stock
2024-01-02 Trost Timothy W. Buy 150 000 Stock Option (right to buy)
2024-01-02 Lubman Ellen Buy 131 900 Stock Option (right to buy)
2024-01-02 Isaacs Randi Buy 200 000 Stock Option (right to buy)
INSIDER POWER
99.28
Last 97 transactions
Buy: 45 258 272 | Sell: 143 550 934

Volume Correlation

Long: 0.30 (neutral)
Short: -0.78 (moderate negative)
Signal:(54.879) Neutral

Werewolf Therapeutics, Correlation

10 Most Positive Correlations
RMRM0.939
APOP0.918
FEYE0.897
SVOK0.88
TLGT0.879
SVAC0.874
GAINL0.874
PAIC0.861
SYBX0.854
TDAC0.851
10 Most Negative Correlations
MMAC-0.959
AMRB-0.922
BOCH-0.893
NETE-0.888
RGP-0.851
SBBP-0.823
SHSP-0.809

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Werewolf Therapeutics, Correlation - Currency/Commodity

The country flag 0.12
( neutral )
The country flag -0.02
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.69
( moderate negative )
The country flag -0.06
( neutral )

Werewolf Therapeutics, Financials

Annual 2023
Revenue: $19.94M
Gross Profit: $18.18M (91.15 %)
EPS: $-1.050
Q4 2023
Revenue: $1.50M
Gross Profit: $1.04M (69.35 %)
EPS: $-0.330
Q3 2023
Revenue: $5.90M
Gross Profit: $5.45M (92.45 %)
EPS: $-0.230
Q2 2023
Revenue: $8.08M
Gross Profit: $7.31M (90.43 %)
EPS: $-0.140

Financial Reports:

No articles found.

Werewolf Therapeutics,

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators